Bottom line
How much do IBBQ and RYOIX overlap?
58% of their top holdings overlap by weight. 17 securities appear in both funds' top 25, making up 50.7% of IBBQ's assets and 40.6% of RYOIX's. They share a meaningful core but differ in the rest of the portfolio.
IBBQ holds far more positions (261 vs 74), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings IBBQ and RYOIX have in common
| Holding | % of IBBQ | % of RYOIX | Overlap |
|---|---|---|---|
| Gilead Sciences, Inc. | 7.39% | 4.49% | 4.49% |
| Vertex Pharmaceuticals Inc. | 7.38% | 4.32% | 4.32% |
| Amgen Inc. | 7.10% | 5.05% | 5.05% |
| Regeneron Pharmaceuticals, Inc. | 5.08% | 2.93% | 2.93% |
| Alnylam Pharmaceuticals, Inc. | 3.19% | 2.36% | 2.36% |
| Revolution Medicines, Inc. | 2.48% | 2.48% | 2.48% |
| Biogen Inc. | 2.29% | 2.13% | 2.13% |
| Illumina, Inc. | 1.98% | 1.94% | 1.94% |
| United Therapeutics Corp. | 1.94% | 1.72% | 1.72% |
| argenx SE | 1.89% | 1.48% | 1.48% |
| Insmed Inc. | 1.83% | 1.79% | 1.79% |
| Incyte Corp. | 1.53% | 1.62% | 1.53% |
| Viatris Inc. | 1.49% | 1.55% | 1.49% |
| Moderna, Inc. | 1.48% | 2.15% | 1.48% |
| Guardant Health, Inc. | 1.35% | 1.72% | 1.35% |
| Neurocrine Biosciences, Inc. | 1.26% | 1.52% | 1.26% |
| BridgeBio Pharma, Inc. | 1.02% | 1.38% | 1.02% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in IBBQ
- Invesco Private Prime Fund — 14.20%
- Invesco Private Government Fund — 5.48%
- Royalty Pharma PLC — 1.90%
- Roivant Sciences Ltd. — 1.71%
- Jazz Pharmaceuticals PLC — 1.16%
- Ascendis Pharma A/S — 1.10%
- Summit Therapeutics Inc. — 1.08%
- Exelixis, Inc. — 1.04%
Only in RYOIX
- Abbvie Inc — 8.17%
- Beone Medicines Ltd — 2.17%
- Natera Inc — 2.12%
- Royalty Pharma Plc — 2.01%
- Roivant Sciences Ltd — 1.66%
- Jazz Pharmaceuticals Plc — 1.42%
- Ionis Pharmaceuticals Inc — 1.35%
- Cytokinetics Inc — 1.35%
Asset mix
| Asset type | IBBQ | RYOIX |
|---|---|---|
| Stocks | 99.9% | 99.6% |
| Cash & short-term funds | 19.7% | 0.6% |
| Repurchase agreements | — | 0.6% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)
Country mix
| Country | IBBQ | RYOIX |
|---|---|---|
| US | 103.8% | 85.8% |
| CH | 1.2% | 3.3% |
| GB | 2.7% | 3.2% |
| IE | 1.9% | 2.7% |
| NL | 2.5% | 1.5% |
| BM | 1.7% | 1.7% |
| FR | 1.5% | — |
| DK | 1.2% | 0.9% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do IBBQ and RYOIX overlap?
What stocks do IBBQ and RYOIX have in common?
Should I own both IBBQ and RYOIX?
Which holds more stocks, IBBQ or RYOIX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.